A prospective study of the pattern of drug prescribing for dysfunctional uterine bleeding in a tertiary care hospital

Kempegowda institute of medical sciences and research hospital0 个研究点目标入组 110 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Subjects between 20-50 years of age diagnosed as dysfunctional uterine bleeding.
•2.Willingness to give written informed consent and availability for regular follow up.

•1. Subjects with pelvic pathologies such as uterine fibroids, endometriosis, endometrial polyps, PCOS and pelvic inflammatory disease.
•2. Pregnant women or lactating women in the first 6 months of postnatal period, women who have had an abortion during the previous 3 months, IUCD or contraceptive pill users.
•3. Presence of medical diseases like cardiac dysfunction, uncontrolled diabetes mellitus, uncontrolled hypertension, liver and renal dysfunction, migraine, thyroid disorders, cerebrovascular disease, past or present neoplastic diseases, thromboembolism and coagulation disorders.
•4. Women on immunosuppressant therapy, anticoagulation therapy, or who have a known hypersensitivity to any of the drugs used in dysfunctional uterine bleeding.
•5. Subjects who have participated in any clinical trial in the past 3 months.

发起方

Kempegowda institute of medical sciences and research hospital